Skip to content
Elypta logo — Advancing cancer detection

Elypta

Advancing cancer detection

Founded 2017 Sweden Sweden 32 employees Grant Total: $107.83M Biotechnology, Health Care

General Information

Company Name Elypta
Founded Year 2017
Location Sweden Sweden
Founders / Decision Makers
Team member
Employees 32
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Elypta. To contact Elypta, visit elypta.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Elypta compare?

A PDF of Elypta and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Elypta soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Elypta

Elypta AB is a Swedish molecular diagnostics company dedicated to advancing cancer detection. The company's innovative approach focuses on reducing cancer mortality by pioneering a metabolism-based liquid biopsy that measures the GAGome, serving as system biomarkers of tumor metabolism. Through the use of machine learning algorithms, Elypta aims to noninvasively detect signatures of cancer. With its first indication expected to be early detection of recurrence in renal cell carcinoma, the company is advancing a broad clinical program across different cancers. Founded in 2017 as a result of several years of research in the Nielsen lab at Chalmers University of Technology in Gothenburg, Sweden, Elypta was established by Francesco Gatto and Jens Nielsen. The company operates within the industries of Biotechnology and Health Care and is headquartered in Sweden. Elypta's latest investment of $1.00M in the form of a grant was received on 28 March 2023, with backing from The Roddenberry Foundation.

Business keywords: Liquid Biopsy, Cancer Detection, Molecular Diagnostics, Glycosaminoglycans, Renal Cell Carcinoma, Clinical Development, Early Detection, Recurrence Surveillance, Treatment Response Monitoring, Medical Imaging, Metabolism-based Approach, Pan-cancer Potential, Mass-spectrometry, Research and Development

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.00M 1
The Roddenberry Foundation
28 Mar 2023
Series A $21.00M 7
Industrifonden, Chalmers Ventures +5
20 Jun 2022
Seed Round kr65.00M 5
Industrifonden, Chalmers Ventures +3
23 Jan 2020
Grant €30.00K 1
EIT Health
01 Oct 2019
Grant €2.30M 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Pre Seed Round kr15.50M 2
Chalmers Ventures, Navigare Ventures
11 Jun 2018
Pre Seed Round kr3.00M 1
Navigare Ventures
01 Jun 2017

Elypta Alternatives & Competitors

View All Alternatives
Elypta vs
Amadix
Amadix Spain

Early cancer detection in blood

Grant
43 employees
Biopharma, Biotechnology
Elypta vs
VisionGate, Inc.
VisionGate, Inc. United States

Leading the Battle Against Lung Cancer through our Early Detection Technology

Venture round
24 employees
Biotechnology, Health Care
Elypta vs
RhoDx, Inc.
RhoDx, Inc. United States

Reducing Cancer Morbidity and Mortality through Early Detection and Monitoring.

3 employees
Biotechnology, Health Care

FAQ About Elypta

Advancing cancer detection
Elypta was founded in 2017.
Elypta is headquartered in Sweden.
Elypta operates in Biotechnology and Health Care. Its work centres on Liquid Biopsy, Cancer Detection, Molecular Diagnostics and Glycosaminoglycans.
Elypta has approximately 32 employees.
Elypta has completed 7 funding rounds, raising a total of $107.83M. The latest funding stage is Grant.
Top alternatives and competitors to Elypta include Amadix, VisionGate, Inc., RhoDx, Inc., Diatech Pharmacogenetics, Singlera Genomics Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elypta and Amadix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Elypta, https://bouncewatch.com/company/elypta-ab, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout